- Home
- App Analytics
- PMcardio - ECG Analysis
- PMcardio - ECG Analysis Vs. Kardia
PMcardio - ECG Analysis vs Kardia Usage & Stats
PMcardio is an AI-powered medical solution that empowers healthcare professionals to interpret ECGs accurately in seconds and diagnose and treat 39 cardiovascular diseases with the confidence of an expert cardiologist. PMcardio is a Class IIb medical device certified under the EU MDR regulation. The app integrates human expertise with cutting-edge AI technology.
PMcardio provides patient management and treatment recommendations based on clinical practice guidelines. Using the standardised traffic-light triage system, PMcardio enables users to triage patients more accurately.
The clinical performance of PMcardio has been benchmarked against general practitioners and cardiologists. PMcardio has demonstrated improved diagnostic performance across all standard evaluation metrics.
Key features:
• ECG Digitisation: PMcardio converts any paper-form or screen-based image of an ECG into a standardised digital waveform.
• ECG Interpretation: PMcardio reads any standard 12-lead ECG and diagnoses it with 38.8% average improved detection.
• Treatment recommendations: PMcardio helps triage & manage patients better thanks to the traffic-light triage system and guideline-adherent treatment recommendations.
• Diagnostic ECG reporting: PMcardio provides a full, professional ECG diagnostic report that can be exported and saved in a digital archive.
DISCLAIMER:
PMcardio is a CE-marked, Class IIb Medical Device under EU regulations. The product is intended to be used by qualified healthcare professionals for the assessment of cardiovascular diseases using ECG data. The application provides diagnostic and treatment recommendations for patients aged 18 years and above.
The electronic instructions for use can be accessed in the about section within the application after logging in or using the link in the footer section of our website. If you are a registered customer, you can request a printed version of the instructions for use by contacting our support. After verifying your eligibility, the printed version of the instructions for use will be sent and delivered within seven days at no additional cost.
Basic UDI-DI: 426073843PMcardio0001H2
Have questions, comments, or feedback? Please get in touch with us at support@powerfulmedical.com.
- Google Play Store
- Free
- Medical
Usage Rank
- -
Kardia works with the FDA-cleared KardiaMobile, KardiaMobile 6L, or KardiaBand personal EKG devices, which can detect the most common arrhythmias in just 30 seconds. The Kardia app is designed to make managing heart care from home easier than ever, giving you the ability to seamlessly record EKGs, share heart data with your doctor remotely, keep track of your health history, and more.
Capture a medical-grade EKG with your Kardia device anytime, anywhere—no patches, wires, or gels required. Get an immediate result from Kardia's Instant Analysis of normal, possible atrial fibrillation, bradycardia, or tachycardia. For additional analysis, you can choose to send the recording to your physician or to one of our partners for a Clinician Review by a cardiologist (US, Australia only) or cardiac care physiologist (UK, Ireland only).
The Kardia system is recommended by leading cardiologists and used by people around the world for accurate EKG recordings. Track your heart health data from home with the medical accuracy your doctor can trust.
NOTE: This app requires KardiaMobile, KardiaMobile 6L, or KardiaBand hardware to record an EKG. Get your Kardia device now at alivecor.com.
- Google Play Store
- Free
- Medical
Usage Rank
#4,164
PMcardio - ECG Analysis vs. Kardia ranking comparison
Compare PMcardio - ECG Analysis ranking trend in the past 28 days vs. Kardia
Kardia#4,164
Rank
PMcardio - ECG Analysis vs. Kardia ranking by country comparison
Compare PMcardio - ECG Analysis ranking trend in the past 28 days vs. Kardia
All categories
No Data Available
Medical
Compare to any site with our free trial
PMcardio - ECG Analysis VS.
Kardia
November 26, 2024